Finanza

Discussioni Tecnici Previsione Stagionalità

Totale attività su Aprea Therapeutics, Inc..

Dati annuali

2018

2019

2020

2021

2022

2023

‪0,00‬

‪‪35,00 M‬‬

‪‪70,00 M‬‬

‪‪105,00 M‬‬

‪‪140,00 M‬‬

Periodo

Valore

Variazione

Variazione %

2023

‪‪22,65 M‬‬

‪‪−7,51 M‬‬

‪−24,89‬%

2022

‪‪30,16 M‬‬

‪‪−26,67 M‬‬

‪−46,93‬%

2021

‪‪56,82 M‬‬

‪‪−35,98 M‬‬

‪−38,77‬%

2020

‪‪92,81 M‬‬

‪‪−40,80 M‬‬

‪−30,54‬%

2019

‪‪133,61 M‬‬

+‪‪67,59 M‬‬

+‪102,37‬%

2018

Dati trimestrali

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪9,00 M‬‬

‪‪18,00 M‬‬

‪‪27,00 M‬‬

‪‪36,00 M‬‬

Periodo

Valore

Variazione

Variazione %

Q3 '24

‪‪26,89 M‬‬

‪‪−3,07 M‬‬

‪−10,25‬%

Q2 '24

‪‪29,96 M‬‬

‪‪−3,24 M‬‬

‪−9,75‬%

Q1 '24

‪‪33,20 M‬‬

+‪‪10,55 M‬‬

+‪46,58‬%

Q4 '23

‪‪22,65 M‬‬

‪‪−3,12 M‬‬

‪−12,09‬%

Q3 '23

‪‪25,77 M‬‬

‪‪−2,91 M‬‬

‪−10,16‬%

Q2 '23

‪‪28,68 M‬‬

‪‪−3,34 M‬‬

‪−10,43‬%

Q1 '23

‪‪32,02 M‬‬

+‪‪1,86 M‬‬

+‪6,18‬%

Q4 '22

‪‪30,16 M‬‬

‪‪−3,47 M‬‬

‪−10,31‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19